— Endo International plc (NASDAQ: ENDP) reported Q3 2019 earnings of $0.60 per share, vs. $0.53 expected. — Revenues fell 2% to $729 million, vs. $709 million expected. — Specialty Products revenues increased 18% to $132 million. — Sterile Injectables revenues grew 11% to $264 million. — FY19 revenues are expected to be between $2.86 billion […]
“— Endo International plc (NASDAQ: ENDP) reported Q3 2019 earnings of $0.60 per share, vs. $0.53 expected. — Revenues fell 2% to $729 million, vs. $709 million expected. — Specialty Products revenues increased 18% to $132 million. — Sterile Injectables revenues grew 11% to $264 million. — FY19 revenues are expected to be between $2.86 billion […]
· November 5, 2019
— Endo International plc (NASDAQ: ENDP) reported Q3 2019 earnings of $0.60 per share, vs. $0.53 expected.
— Revenues fell 2% to $729 million, vs. $709 million expected.
— Specialty Products revenues increased 18% to $132 million.
— Sterile Injectables revenues grew 11% to $264 million.
— FY19 revenues are expected to be between $2.86 billion and $2.89 billion.
— FY19 adjusted EPS from continuing operations is expected to be $2.10 and $2.25.
— ENDP shares were down 3% in premarket hours on Tuesday.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
